Literature DB >> 30074262

Stem cell- and gene-based therapies as potential candidates in Alzheimer's therapy.

Seyede Atefe Hosseini1, Rezvan Mohammadi1, Somaye Noruzi1, Yousef Mohamadi2, Mitra Azizian3, Seyed Mojta Mousavy4, Faezeh Ghasemi5, AmirReza Hesari5, Amirhossein Sahebkar6,7, Reza Salarinia1, Arad Mobasher Aghdam8, Hamed Mirzaei9.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, which is associated with impairments of memory, thinking, language, and reasoning. Despite extensive research aiming at the treatment of AD, durable and complete remissions are rare. Hence, new therapeutic approaches are required. Among various therapeutic approaches, stem cells (ie, neural stem cells, mesenchymal stem cells, and embryonic stem cells) and delivery of protective genes such as encoding nerve growth factor, APOE, and glial cell-derived neurotrophic factor have generated promise in AD therapy. Here, we summarized a variety of effective therapeutic approaches (ie, stem cells, and genes) in AD therapy.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; exosome; gene therapy; microRNA; stem cell; therapy

Mesh:

Substances:

Year:  2018        PMID: 30074262     DOI: 10.1002/jcb.27202

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer's Disease.

Authors:  Henrique C Campos; Deidiane Elisa Ribeiro; Debora Hashiguchi; Deborah Y Hukuda; Christiane Gimenes; Simone A A Romariz; Qing Ye; Yong Tang; Henning Ulrich; Beatriz Monteiro Longo
Journal:  Stem Cell Rev Rep       Date:  2022-01-08       Impact factor: 5.739

Review 2.  The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.

Authors:  Qing Xia; XinYu Yang; JiaBin Shi; ZiJie Liu; YaHui Peng; WenJing Wang; BoWen Li; Yu Zhao; JiaYing Xiao; Lei Huang; DaYong Wang; Xu Gao
Journal:  Mol Neurobiol       Date:  2021-04-29       Impact factor: 5.590

3.  The Pluripotency Factor Nanog Protects against Neuronal Amyloid β-Induced Toxicity and Oxidative Stress through Insulin Sensitivity Restoration.

Authors:  Ching-Chi Chang; Hsin-Hua Li; Sing-Hua Tsou; Hui-Chih Hung; Guang-Yaw Liu; Tatiana A Korolenko; Te-Jen Lai; Ying-Jui Ho; Chih-Li Lin
Journal:  Cells       Date:  2020-05-27       Impact factor: 6.600

Review 4.  Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseases.

Authors:  Jacopo Meldolesi
Journal:  Mol Biomed       Date:  2021-06-20

Review 5.  Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases.

Authors:  Fatemeh Zahedipour; Seyede Atefe Hosseini; Neil C Henney; George E Barreto; Amirhossein Sahebkar
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

Review 6.  Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?

Authors:  Giuseppe Alastra; Luigi Aloe; Vito Antonio Baldassarro; Laura Calzà; Maura Cescatti; Jason Thomas Duskey; Maria Letizia Focarete; Daria Giacomini; Luciana Giardino; Valentina Giraldi; Luca Lorenzini; Marzia Moretti; Irene Parmeggiani; Michele Sannia; Giovanni Tosi
Journal:  Front Neurosci       Date:  2021-07-15       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.